Grifols (GRFS) FCF Margin Growth (1y) (2011 - 2020)
Grifols (GRFS) FCF Margin Growth (1y) (2011 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 1,688.00 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | -1,334.00 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 1,096.00 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | -647.00 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | -158.00 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1,388.00 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 3,383.00 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 1,020.00 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 69.00 |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 2,265.00 |
| Dec 31, 2019 | -345.00 |
| Mar 31, 2019 | -2,356.00 |
| Dec 31, 2018 | -503.00 |
| Jun 30, 2018 | -636.00 |
| Mar 31, 2018 | -463.00 |
| Dec 31, 2017 | 831.00 |
| Dec 31, 2016 | -1,996.00 |
| Sep 30, 2016 | 256.00 |
| Dec 31, 2015 | 4,872.00 |
| Sep 30, 2015 | -6,119.00 |
| Jun 30, 2015 | 2,249.00 |
| Mar 31, 2015 | -1,189.00 |
| Dec 31, 2014 | -1,952.00 |
| Sep 30, 2014 | 6,640.00 |
| Jun 30, 2014 | -2,697.00 |
| Mar 31, 2014 | 214.00 |
| Dec 31, 2013 | 0.00 |
| Sep 30, 2013 | -796.00 |
| Jun 30, 2013 | -604.00 |